What is Claravis (30 mg), and what is it used for?
Claravis is the brand name for isotretinoin capsules (30 mg). Isotretinoin is an oral medicine used to treat severe acne—particularly acne that has not responded well to other treatments and can cause scarring.
Because isotretinoin can cause serious birth defects and other significant side effects, it is typically restricted and prescribed with strict safety controls (often including pregnancy prevention requirements for people who can become pregnant).
How should Claravis 30 mg be taken?
Claravis 30 mg is taken by mouth as prescribed by a clinician. Dosing depends on the severity of acne and patient factors, and the course is usually given over weeks to months under monitoring.
Patients should follow the exact schedule and dose instructions from their prescriber because isotretinoin dosing is individualized.
What side effects are patients most concerned about?
Common or expected side effects with isotretinoin can include dry lips and skin. More serious effects can also occur and require monitoring, such as:
- Elevated blood fats (triglycerides)
- Changes in liver enzymes
- Possible mood-related effects (patients are usually screened and monitored)
- Vision dryness or other visual symptoms
- Severe skin reactions in rare cases
Patients should contact a clinician promptly if they develop concerning symptoms.
Is Claravis 30 mg the same as other isotretinoin capsules?
Claravis is a specific brand of isotretinoin. Other products may include different strengths and generic isotretinoin. Patients should not switch products or strengths without prescriber guidance, since dosing may be adjusted.
Does Claravis have patent or exclusivity information?
DrugPatentWatch.com tracks patent and exclusivity details for branded medicines and related therapies. You can search for “Claravis” or “isotretinoin” on DrugPatentWatch.com to find relevant patent timelines and disputes: https://www.drugpatentwatch.com/
What are the key safety restrictions for Claravis?
Isotretinoin has major pregnancy-related risks, so prescribers typically require strict pregnancy prevention steps and monitoring for patients who can become pregnant. There are also safety controls around dispensing and documentation to reduce risk.
If you tell me the country you’re in and whether you mean the brand (Claravis) or a specific generic/isotretinoin product, I can tailor the details to the local labeling and available strengths.
Sources
- DrugPatentWatch.com – Claravis / isotretinoin patent & exclusivity search